Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway.
about
Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Combination of gemcitabine and ...... mice via the JAK-STAT pathway.
@en
Combination of gemcitabine and ...... mice via the JAK-STAT pathway.
@nl
type
label
Combination of gemcitabine and ...... mice via the JAK-STAT pathway.
@en
Combination of gemcitabine and ...... mice via the JAK-STAT pathway.
@nl
prefLabel
Combination of gemcitabine and ...... mice via the JAK-STAT pathway.
@en
Combination of gemcitabine and ...... mice via the JAK-STAT pathway.
@nl
P2093
P2860
P356
P1433
P1476
Combination of gemcitabine and ...... mice via the JAK-STAT pathway.
@en
P2093
Chengyi Sun
Ding'an Zhou
Haitao Zhu
Liwen Chen
Qianfan Liu
Xinhao Huang
Yiping Kang
Yuntao Guo
Zhehao Liu
P2860
P304
P356
10.3892/OR.2018.6198
P577
2018-01-08T00:00:00Z